CBCS BSL3 unit at Karolinska Institute
BSL3 Biomedicum is a fully equipped facility performing a wide range of research activities with any pathogens that require a biosafety level 3 laboratory. The facility is equipped with state-of-the-art equipment such as liquid-handling robotics, plate reader, and flow cytometry and expertise staff specialized in high-throughput screening, as exemplified in Figure 1.
Figure 1. An example of high-throughput antiviral assays available at BSL3 Biomedicum. An image-based screening assay was developed in collaboration with Dr. Charlotte Stadler (Kaimal et al. biorxiv, 2022) and a cell viability assay in collaboration with Dr. Marianna Tampere.